Back to Journals » International Medical Case Reports Journal » Volume 6

Lyme disease: case report of persistent Lyme disease from Pulaski County, Virginia

Authors Palmieri JR , King S, Case M, Santo A

Received 9 July 2013

Accepted for publication 23 October 2013

Published 5 December 2013 Volume 2013:6 Pages 99—105

DOI https://doi.org/10.2147/IMCRJ.S51240

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 5



James R Palmieri,1 Scott King,1 Matthew Case,1 Arben Santo2

1Department of Microbiology, Infectious and Emerging Diseases, 2Department of Pathology, Edward Via College of Osteopathic Medicine, Blacksburg, VA, USA

Abstract: A 50-year-old woman from Pulaski, Virginia, presented to a local clinic with headaches, fever, generalized joint pain, excessive thirst and fluid intake, and a progressing rash on her back. On physical examination, she had a large circular red rash on her back with a bull's-eye appearance, 16 × 18 cm in diameter. Serologic tests confirmed a diagnosis of Lyme disease. The patient could recall a walk through the woods 3 weeks prior, although she never noticed a tick on her body. Following a prolonged course of antibiotics, this case report presents a patient with ongoing symptoms consistent with post-treatment Lyme disease.

Keywords: arthritis, chronic Lyme disease (CLD), ELISA, erythema migrans, ixodid ticks, Lyme disease, post-treatment Lyme disease syndrome (PTLDS), Western blotting

Creative Commons License © 2013 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.